Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study

NCT02786576 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02786576
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02786576 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
July 5, 2016
Completion date
January 7, 2019
Enrollment
236 (actual)
Sites
83

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa